Global Infection Control And Biosafety Products Market Analysis By Product Type[Disinfection Products (Surface disinfectants, Hand sanitizers, Disinfectant wipes, Others), Personal Protective Equipment (Masks (surgical, N95, respirators), Gloves (latex, nitrile, vinyl), Gowns and coveralls, Face shields and goggles, Sterilization Equipment, Autoclaves, Ultrasonic cleaners, Irradiation equipment), Monitoring and Surveillance Products (Environmental monitoring systems, Microbial air samplers, Others)], By End-Use[Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, DIagnostic Laboratories, Ambulatory Surgical Centers, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: May 2024
- Report ID: 13760
- Number of Pages: 208
- Format:
- keyboard_arrow_up
Quick Navigation
Report Overview
Infection control and biosafety products are essential tools designed to prevent the spread of infectious diseases and ensure biosafety in healthcare and laboratory environments. These products include disinfectants, sterilization equipment, protective barriers, and containment units. The infection control and biosafety products market is driven by increasing awareness of infectious diseases, stringent regulatory standards for health and safety, and technological advancements in sterilization methods.
The market encompasses a range of sectors, including hospitals, clinics, laboratories, and pharmaceutical companies, all of which require effective solutions to manage biological hazards. Growth in this market can be attributed to the rising incidence of hospital-acquired infections and the global emphasis on laboratory safety. As healthcare facilities worldwide continue to expand and upgrade their safety protocols, the demand for these products is expected to grow, supporting the market’s expansion.
The report on Infection Control and Biosafety Products Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global infection control and biosafety products market is segmented on the basis of type, application, and geography.
Key Market Segments
Product Type
- Disinfection Products
- Surface disinfectants
- Hand sanitizers
- Disinfectant wipes
- Others
- Personal Protective Equipment
- Masks (surgical, N95, respirators)
- Gloves (latex, nitrile, vinyl)
- Gowns and coveralls
- Face shields and goggles
- Sterilization Equipment
- Autoclaves
- Ultrasonic cleaners
- Irradiation equipment
- Monitoring and Surveillance Products
- Environmental monitoring systems
- Microbial air samplers
- Others
End-Use
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- DIagnostic Laboratories
- Ambulatory Surgical Centers
- Others
Drivers
Increased Awareness and Stringent Regulations
The driver propelling the growth of the global infection control and biosafety products market is the heightened awareness of infectious diseases and the implementation of stringent regulations to mitigate their spread. Governments and healthcare organizations worldwide are enforcing strict guidelines and protocols for infection prevention and control, leading to a rising demand for effective biosafety products such as disinfectants, sterilization equipment, and personal protective equipment (PPE).
The World Health Organization (WHO) reports that healthcare-associated infections (HAIs) affect millions of patients worldwide annually, contributing to significant morbidity, mortality, and healthcare costs. The WHO estimates that approximately 7% of patients in developed countries and 10% in developing countries acquire at least one HAI during their hospital stay.
Restraints
High Cost of Advanced Technologies
A significant restraint facing the global infection control and biosafety products market is the high cost associated with advanced technologies and specialized equipment. While there is a growing demand for innovative solutions to combat infectious diseases, the adoption of cutting-edge infection control products may be hindered by their prohibitive costs. This can particularly affect healthcare facilities in developing regions with limited financial resources, potentially slowing down market expansion in these areas.
A study published in the Journal of Hospital Infection found that the cost of implementing enhanced infection control measures, such as the use of advanced disinfection and sterilization technologies, accounted for up to 20% of the total hospital budget in some healthcare facilities.
Opportunities
Technological Advancements and Product Innovations
An opportunity for growth in the global infection control and biosafety products market lies in technological advancements and continuous product innovations. Manufacturers are investing in research and development to introduce more efficient, user-friendly, and cost-effective solutions for infection prevention and biosafety. Opportunities abound for the development of novel disinfection methods, advanced sterilization technologies, and intelligent PPE with enhanced protective features, catering to the evolving needs of healthcare facilities, laboratories, and other end-users.
Trends
Increasing Focus on Antimicrobial Materials and Surfaces
A notable trend shaping the global infection control and biosafety products market is the increasing focus on antimicrobial materials and surfaces. With the emergence of antimicrobial-resistant pathogens and the heightened awareness of surface transmission of infectious agents, there is a growing demand for products integrated with antimicrobial properties. This trend is driving the adoption of antimicrobial coatings, textiles, and surfaces in healthcare settings, public spaces, and consumer products, contributing to enhanced infection prevention strategies and bolstering market growth.
According to a study published in the American Journal of Infection Control, the implementation of antimicrobial surfaces in healthcare settings can reduce surface contamination by up to 90% and contribute to a significant reduction in HAIs.
Key Regions
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Market Key Players
- 3M Company
- STERIS plc
- Ecolab Inc.
- Johnson & Johnson Services Inc.
- Halyard Health Inc. (now part of Owens & Minor)
- Cardinal Health Inc.
- Becton Dickinson and Company (BD)
- Getinge AB
- Thermo Fisher Scientific Inc.
- Belimed AG
- Mölnlycke Health Care AB
- Advanced Sterilization Products (ASP)
- Danaher Corporation
- Reckitt Benckiser Group plc
- Sempermed USA Inc.
- DuPont de Nemours Inc.
Report Scope
Report Features Description Base Year for Estimation 2023 Historic Period 2018-2022 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Product Type[Disinfection Products (Surface disinfectants, Hand sanitizers, Disinfectant wipes, Others), Personal Protective Equipment (Masks (surgical, N95, respirators), Gloves (latex, nitrile, vinyl), Gowns and coveralls, Face shields and goggles, Sterilization Equipment, Autoclaves, Ultrasonic cleaners, Irradiation equipment), Monitoring and Surveillance Products (Environmental monitoring systems, Microbial air samplers, Others)], By End-Use[Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, DIagnostic Laboratories, Ambulatory Surgical Centers, Others) Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape 3M Company, STERIS plc, Ecolab Inc., Johnson & Johnson Services Inc., Halyard Health Inc. (now part of Owens & Minor), Cardinal Health Inc., Becton Dickinson and Company (BD), Getinge AB, Thermo Fisher Scientific Inc., Belimed AG, Mölnlycke Health Care AB, Advanced Sterilization Products (ASP), Danaher Corporation, Reckitt Benckiser Group plc, Sempermed USA Inc., DuPont de Nemours Inc. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Infection Control and Biosafety Products MarketPublished date: May 2024add_shopping_cartBuy Now get_appDownload Sample - Disinfection Products
- 3M Company Company Profile
- STERIS plc
- Ecolab Inc.
- Johnson & Johnson Services Inc.
- Halyard Health Inc. (now part of Owens & Minor)
- Cardinal Health Inc.
- Becton Dickinson and Company (BD)
- Getinge AB
- Thermo Fisher Scientific Company Profile
- Belimed AG
- Mölnlycke Health Care AB
- Advanced Sterilization Products (ASP)
- Danaher Corporation Company Profile
- Reckitt Benckiser Group PLC Company Profile
- Sempermed USA Inc.
- DuPont de Nemours Inc.
- settingsSettings
Our Clients
Single User $4,599 $3,499 USD / per unit save 24% | Multi User $5,999 $4,299 USD / per unit save 28% | Corporate User $7,299 $4,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,499) | Buy Now ($ 4,299) | Buy Now ($ 4,999) |